Two Sigma Investments
FLGT icon

Two Sigma Investments’s Fulgent Genetics FLGT Stock Holding History

Two Sigma Investments’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-21,500
Closed -$2.16M – 3233
2021
Q4 		$2.16M Sell
21,500
-11,400
-35% -$1M ﹤0.01% 1850
2021
Q3 		$2.96M Sell
32,900
-1,900
-5% -$173K 0.01% 1617
2021
Q2 		$3.21M Buy
34,800
+26,000
+295% +$2.08M 0.01% 1499
2021
Q1 		$850K Buy
+8,800
New +$908K ﹤0.01% 2462

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Two Sigma Investments's FLGT Position: Q1 2026 in Review

Two Sigma Investments increased its Fulgent Genetics (FLGT) stake by 8.4% in Q1 2026, buying an estimated $539K and bringing the position to 322,189 shares worth $5.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1962.

Two Sigma Investments first reported a position in FLGT in Q4 2019 and has held it in 12 quarters since. The position peaked at $7.81M in Q4 2025. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Two Sigma Investments held 322,189 shares of Fulgent Genetics worth $5.12M as of Q1 2026.
  • Two Sigma Investments bought 24,834 Fulgent Genetics shares in Q1 2026, an estimated $539K.
  • Fulgent Genetics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1962 holding.
  • Two Sigma Investments first reported a position in Fulgent Genetics in Q4 2019 and has held it in 12 quarters since.
  • Two Sigma Investments's Fulgent Genetics position peaked at $7.81M in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.